The human ROX gene: genomic structure and mutation analysis in human breast tumors.
AuthorsLo Nigro, C
Ledbetter, D H
Liscia, D S
AffiliationTelethon Institute of Genetics and Medicine (TIGEM), San Raffaele Biomedical Science Park, Milan, Italy.
MetadataShow full item record
AbstractWe have recently isolated a human gene, ROX, encoding a new member of the basic helix-loop-helix leucine zipper protein family. ROX is capable of heterodimerizing with Max and acts as a transcriptional repressor in an E-box-driven reporter gene system, while it was found to activate transcription in HeLa cells. ROX expression levels vary during the cell cycle, being down-regulated in proliferating cells. These biological properties of ROX suggest a possible involvement of this gene in cell proliferation and differentiation. The ROX gene maps to chromosome 17p13.3, a region frequently deleted in human malignancies. Here we report the genomic structure of the human ROX gene, which is composed of six exons and spans a genomic region of less than 40 kb. In an attempt to identify possible inactivating mutations in the ROX gene in human breast cancer, we performed a single-strand conformation polymorphism analysis of its coding region in 16 sporadic breast carcinomas showing loss of heterozygosity in the 17p13.3 region. No mutations were found in this analysis. Five nucleotide polymorphisms were identified in the ROX gene, three of which caused an amino acid substitution. These nucleotide changes were present in the peripheral blood DNAs of both the patients and the control individuals. In vitro translated assays did not show a significant decrease in the ability of the ROX mutant proteins to bind DNA or to repress transcription of a driven reporter gene in HEK293 cells. Despite experimental evidence that ROX might act as a tumor suppressor gene, our data suggest that mutations in the coding region of ROX are uncommon in human breast tumorigenesis.
CitationThe human ROX gene: genomic structure and mutation analysis in human breast tumors. 1998, 49 (2):275-82 Genomics
- Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor.
- Authors: Meroni G, Reymond A, Alcalay M, Borsani G, Tanigami A, Tonlorenzi R, Lo Nigro C, Messali S, Zollo M, Ledbetter DH, Brent R, Ballabio A, Carrozzo R
- Issue date: 1997 May 15
- Mlx, a new Max-like bHLHZip family member: the center stage of a novel transcription factors regulatory pathway?
- Authors: Meroni G, Cairo S, Merla G, Messali S, Brent R, Ballabio A, Reymond A
- Issue date: 2000 Jul 6
- Expression and mutation analysis of genes that encode the Myc antagonists Mad1, Mxi1 and Rox in acute leukaemia.
- Authors: Guo XL, Pan L, Zhang XJ, Suo XH, Niu ZY, Zhang JY, Wang F, Dong ZR, Da W, Ohno R
- Issue date: 2007 Jun
- TCFL4: a gene at 17q21.1 encoding a putative basic helix-loop-helix leucine-zipper transcription factor.
- Authors: Bjerknes M, Cheng H
- Issue date: 1996 Nov 28
- Molecular analysis of a Myc antagonist, ROX/Mnt, at 17p13.3 in human lung cancers.
- Authors: Takahashi T, Konishi H, Kozaki K, Osada H, Saji S, Takahashi T, Takahashi T
- Issue date: 1998 Apr